DeepMed Research

Ferring Pharmaceuticals, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.ferringusa.com

Clinical Trials

A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation

Phase 3

Completed

Conditions: Infertility

Interventions: Drug: REKOVELLE (Follitropin Delta)
Other: GONAL-F (Follitropin Alfa)

First Posted Date: 2022-03-02

Last Posted Date: 2025-04-02

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 302

Registration Number: NCT05263388

Locations: 🇬🇧
Ferring Investigational Site, Liverpool, United Kingdom

FIRMAGON Intensive Drug Monitoring Protocol

Completed

Conditions: Prostate Cancer

Interventions: Other: Degarelix Cohort

First Posted Date: 2022-01-06

Last Posted Date: 2023-02-08

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 2193

Registration Number: NCT05181800

Locations: 🇨🇳
China Primary Healthcare Foundation, Beijing, China

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

Phase 1

Completed

Conditions: Infertility, Female

Interventions: Drug: A MENOPUR solution for injection in pre-filled pen, 600 IU/0.96 mL
Drug: A MENOPUR powder including solvent for solution for injection, 75 IU

First Posted Date: 2021-05-26

Last Posted Date: 2022-08-24

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 95

Registration Number: NCT04902131

Locations: 🇨🇳
Ferring investigational site, Nanjing, China

MEDAM (Menopur Retrospective Data prograM)

Completed

Conditions: Infertility, Female

Interventions: Other: No intervention

First Posted Date: 2021-05-06

Last Posted Date: 2022-01-25

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 11488

Registration Number: NCT04876300

Locations: 🇫🇷
Ferring investigational site, Rennes, France

Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population

Completed

Conditions: Bowel Cleansing

Interventions: Other: No intervention

First Posted Date: 2021-04-21

Last Posted Date: 2024-02-26

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 3000

Registration Number: NCT04852120

Locations: 🇨🇳
Ferring Investigational Site, Xian, China

Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment

Withdrawn

Conditions: Infertility, Female

First Posted Date: 2021-03-24

Last Posted Date: 2023-01-25

Lead Sponsor: Ferring Pharmaceuticals

Registration Number: NCT04814940

Locations: 🇮🇱
Assuta Medical Center Ltd, Tel-aviv, Israel

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women

Phase 3

Completed

Conditions: Infertility

Interventions: Drug: Follitropin Delta (FE 999049)
Drug: Follitropin Alfa (GONAL-F)

First Posted Date: 2021-02-26

Last Posted Date: 2025-01-24

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 220

Registration Number: NCT04773353

Locations: 🇮🇳
Ferring Investigational Site, New Delhi, India

General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

Completed

Conditions: Cervical Ripening
Pregnancy

First Posted Date: 2021-02-26

Last Posted Date: 2023-04-26

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 409

Registration Number: NCT04773314

Locations: 🇯🇵
Osaka University Hospital (there may be other sites in this country), Osaka, Japan

NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

Completed

Conditions: Adverse Drug Event

Interventions: Other: NOCDURNA Cohort
Other: LUTS Cohort

First Posted Date: 2021-02-05

Last Posted Date: 2024-07-17

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 1099545

Registration Number: NCT04740645

Locations: 🇩🇪
German health care register, BIPS (there may be other sites), Bremen, Germany

Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)

Completed

Conditions: Infertility, Female

First Posted Date: 2020-12-04

Last Posted Date: 2025-04-01

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 728

Registration Number: NCT04654039

Locations: 🇰🇷
Design Hospital, Jeonju, Korea, Republic of
🇰🇷
CHA university Bundang medical center, 59, Yatap-ro, Bundang-gu, Seongnam, Korea, Republic of
🇰🇷
Pyeongchon Maria, 8/9F, Olympic Sports Center120, Dongan-ro, Dongan-gu, Anyang, Korea, Republic of

and more 12 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy